αIFN and ribavirin combination therapy r
αIFN and ribavirin combination therapy reduces the occurrence of breakthrough in chronic hepatitis C
✍
A. Bellobuono; S. Tempini; G.M. Idéo; P. Brasca; L. Mondazzi; G. Antonelli; G. I
📂
Article
📅
2000
🏛
Elsevier Science
🌐
English
⚖ 153 KB